Linda K. S. Leung

A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma

Stephen L. Chan, Frankie Mo, Sze Chuen Cesar Wong et al. · Cancer · 2011 · 70 citations · Full text

Medicine, Immunology, Oncology +15

Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant

Ka‐Fai To, Joanna H. Tong, King SF Yeung et al. · Journal of Thoracic Oncology · 2013 · 69 citations · Full text

Medicine, Molecular Biology, Oncology +15

Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma – clinical application of health-related quality-of-life data

Leung Li, Frankie Mo, Stephen L. Chan et al. · BMC Cancer · 2017 · 53 citations · Full text

Medicine, Oncology, Cancer Control +15

Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network

Edwin P. Hui, Linda K. S. Leung, Terence Chuen Wai Poon et al. · Supportive Care in Cancer · 2010 · 47 citations

Medicine, Oncology, Clinical Decision Support +12

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Herbert H. Loong, Carlos King Ho Wong, Linda K. S. Leung et al. · Cost Effectiveness and Resource Allocation · 2020 · 13 citations · Full text

Medicine, Oncology, Pharmacology +15